Biofrontera AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other
pharmaceutical manufacturers in Europe:
sales of 51.83 million Norwegian Kroner [US$6.63 million]
of which 100%
was Vitamin K2/MenaQ7),
Biotec Pharmacon ASA
(71.90 million Norwegian Kroner [US$9.19 million]
Swedencare AB (publ)
based in Sweden
(53.72 million Swedish Kronor [US$6.36 million]
Biofrontera AG reported sales of 6.13 million Euro (US$7.53 million)
December of 2016.
increase of 48.1%
versus 2015, when the company's sales were 4.14 million Euro.